Award
NIH Reporter #5R44GM146506-03
Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestines
Recipient
VITAKEY, INC.
Award Amount
$607,851.00
Ceiling
$607,851.00
Awarded
September 02, 2026
Identifier
5R44GM146506-03
Development of a stable probiotic formulation for enteral feeding patients to prevent antibiotic-associated diarrhea, including evaluation in mouse models and aiming for clinical efficacy and long-term shelf stability.
Description
This project involves customizing and further developing an oral delivery platform formulation for stabilizing microbes in a liquid for use by patients on enteral feeding (EF) nutritional formula. The goal is to create a probiotic formulation that maintains stability and viability in EF formulas and upon consumption, addressing issues of shelf stability, dosage consistency, and contamination risk.